ruthenium has been researched along with Malignant Melanoma in 63 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 38 (60.32) | 18.7374 |
1990's | 1 (1.59) | 18.2507 |
2000's | 7 (11.11) | 29.6817 |
2010's | 6 (9.52) | 24.3611 |
2020's | 11 (17.46) | 2.80 |
Authors | Studies |
---|---|
Arora, AK; Cohen, VML; Damato, BE; Hay, G; Negretti, GS; O'Day, RFJ; Roelofs, KA; Sagoo, MS; Stoker, I | 1 |
Coupland, SE; Eibenberger, K; Heimann, H; Hussain, R; Krishna, Y | 1 |
Brindell, M; Ganeshpandian, M; Gopinath, P; Manjunathan, T; Mazuryk, O; Peters, S; Pillai, RS; Sumithaa, C | 1 |
Chen, D; Deng, YA; Gao, F; Li, GK; Ren, X; Tang, SJ; Wang, MF; Yang, R; Zhang, D | 1 |
Fu, J; Guo, S; Li, X; Liu, Z; Song, G; Song, X; Tian, Z; Wu, X; Xu, M; Xu, Z; Yang, J; Zhu, D | 1 |
Amenuvor, G; Hussan, A; Meyer, D; Moyo, B; Sitole, L | 1 |
Fandzloch, M; Gubernator, J; Jaromin, A; Lewińska, A; Sitkowski, J; Wiśniewska, J; Wojtczak, A; Zaremba-Czogalla, M; Łakomska, I | 1 |
Archer, SA; Botchway, SW; Fairbanks, SD; Haycock, JW; MacNeil, S; Raza, A; Smitten, KL; Thomas, JA | 1 |
Heikkonen, J; Jouhi, S; Kivelä, TT; Raivio, V; Reijonen, V; Täll, M | 1 |
Dunst, J; Jiang, P; Kandzia, G; Luetzen, U; Neumann, D; Purtskhvanidze, K; Roider, J; Siebert, FA | 1 |
Batista, AA; Ferreira, NH; Oliveira, KM; Orenha, RP; Parreira, RLT; Ribeiro, AB; Rinaldi-Neto, F; Squarisi, IS; Tavares, DC | 1 |
Chouai, A; Dorsey, C; Hennigar, R; Kohler, L; Lincoln, R; McFarland, SA; Monro, S; Stephenson, M; Thummel, RP; Yin, H; Zong, R | 1 |
Budzisz, E; Czyz, M; Kupcewicz, B; Majchrzak, K; Pastuszko, A | 1 |
Albrecht, M; Brabec, V; Donnelly, K; Kasparkova, J; Mueller, T; Muenzner, JK; Novohradsky, V; Rehm, T; Schmitt, F; Schobert, R | 1 |
Hong, Y; McCrate, A; Meyer, K; Nielsen, M; Rani-Beeram, S; Swavey, S | 1 |
Faldum, A; Jochem, T; Schoepfer, K; Stoffelns, BM | 1 |
Barry, NP; Juillerat-Jeanneret, L; Schmitt, F; Therrien, B | 1 |
Hong, Y; Swavey, S; Sweigert, P; Xu, Z | 1 |
Kovacević, N; Vekić, B; Vrtar, M | 1 |
Brindell, M; Elmroth, SK; Kuliś, E; Stochel, G; Urbańska, K | 1 |
Koch, N; Mourtada, F; Newhauser, W | 1 |
Ehlers, N; Isager, P; Overgaard, J; Urbak, SF | 1 |
Atilla-Gokcumen, GE; Bregman, H; Contractor, R; Flaherty, KT; Haass, NK; Herlyn, M; Kulp, AN; Meggers, E; Smalley, KS; Soengas, MS; Williams, DS | 1 |
Ang, WH; Dyson, PJ; Govindaswamy, P; Juillerat-Jeanneret, L; Schmitt, F; Süss-Fink, G; Therrien, B | 1 |
Foerster, MH | 1 |
Bornfeld, N; Foerster, MH; Meyer-Schwickerath, G; Schmitt, G; Schulz, U; Wessing, A | 1 |
Giraldi, T; Mestroni, G; Sava, G; Zassinovich, G; Zorzet, S | 1 |
Foerster, MH; Meyer-Schwickerath, G; Wessing, A | 1 |
Busse, H; Müller, RP | 1 |
Foerster, M; Fried, M; Wessing, A | 1 |
Foerster, MH; Fried, M; Meyer-Schwickerath, G; Wessing, A | 2 |
Bujara, K; Hallermann, D | 1 |
Busse, H; Klein, J; Müller, RP | 1 |
Lommatzsch, PK | 7 |
Furdová, A; Oláh, Z | 1 |
Anghileri, LJ | 1 |
Hallermann, D | 1 |
Hallerman, D; Lüllwitz, W; Schroeder, W | 1 |
Anghileri, LJ; Crone-Escanye, MC; Marchal, C; Matrat, M; Robert, J | 1 |
Bievelez, B; Bonnet, M; Delaroche, G; Gérard, JP; Grange, JD; Guillaubey, Y; Jean-Louis, B; Mere, P; Quintero, P; Santamaria, E | 1 |
Guthoff, R; Hallermann, D; Steinhorst, U; von Domarus, D | 1 |
Bornfeld, N; Foerster, MH; Gerke, E; Kissinger, A; Meyer-Schwickerath, G; Wessing, A | 1 |
Eichler, C; Fuhrmann, P; Hertel, A; Lommatzsch, PK | 1 |
af Trampe, E; Kock, E; Lax, I; Lundell, G; Seregard, S | 1 |
Keppler, BK; Rupp, W | 1 |
Binder, W; Seitz, W; Steinkogler, FJ | 1 |
Busse, H; Haverkamp, U; Kroll, P; Müller, RP; Pötter, R | 1 |
Ballin, R; Lommatzsch, PK; Weise, B | 1 |
Bonnet, M; Burillon, C; Gerard, JP; Grange, JD | 1 |
Busse, H; Gast, E; Kroll, P; Muller, RP | 1 |
Bievelez, B; Bonnet, M; Burillon, C; Gérard, JP; Grange, JD; Philippon, B | 1 |
Hasenfratz, G | 1 |
Ballin, R; Drost, H; Lommatzsch, PK; Ratajek, B | 1 |
Busse, H; Müller, RP; Schmidt, H | 1 |
Binder, W; Menapace, R | 1 |
Lapis, K; Radnót, M | 1 |
63 other study(ies) available for ruthenium and Malignant Melanoma
Article | Year |
---|---|
Long-term visual outcomes after ruthenium plaque brachytherapy for posterior choroidal melanoma.
Topics: Brachytherapy; Choroid Neoplasms; Follow-Up Studies; Humans; Macular Degeneration; Melanoma; Retinal Diseases; Retrospective Studies; Ruthenium; Ruthenium Radioisotopes | 2023 |
Ruthenium
Topics: Brachytherapy; Humans; Leiomyoma; Melanoma; Retrospective Studies; Ruthenium; Ruthenium Radioisotopes; Uveal Neoplasms | 2023 |
Nanoencapsulation of Ru(
Topics: Antineoplastic Agents; Biological Products; Caspases; Cell Line, Tumor; Cell Proliferation; Cymenes; Humans; Liposomes; Melanoma; Molecular Structure; Organometallic Compounds; Prospective Studies; Ruthenium; Zingiber officinale | 2022 |
In vivo Realization of Dual Photodynamic and Photothermal Therapy for Melanoma by Mitochondria Targeting Dinuclear Ruthenium Complexes under Civil Infrared Low-power Laser.
Topics: Cell Line, Tumor; Humans; Lasers; Melanoma; Mitochondria; Photochemotherapy; Photosensitizing Agents; Photothermal Therapy; Ruthenium | 2022 |
A Half-Sandwich Ruthenium(II) (N^N) Complex: Inducing Immunogenic Melanoma Cell Death in Vitro and in Vivo.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Coordination Complexes; Immunogenic Cell Death; Melanoma; Mice; Ruthenium | 2023 |
Investigating the antitumor effects of a novel ruthenium (II) complex on malignant melanoma cells: An NMR-based metabolomic approach.
Topics: Antineoplastic Agents; Cell Line, Tumor; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Melanoma; Ruthenium | 2023 |
Nanoencapsulation of a ruthenium(ii) complex with triazolopyrimidine in liposomes as a tool for improving its anticancer activity against melanoma cell lines.
Topics: Antineoplastic Agents; Capsules; Cell Line, Tumor; Coordination Complexes; Humans; Hydrophobic and Hydrophilic Interactions; Liposomes; Melanoma; Nanostructures; Pyrimidines; Ruthenium; Triazoles | 2020 |
A Dinuclear Ruthenium(II) Complex Excited by Near-Infrared Light through Two-Photon Absorption Induces Phototoxicity Deep within Hypoxic Regions of Melanoma Cancer Spheroids.
Topics: Antineoplastic Agents; Coordination Complexes; Humans; Infrared Rays; Melanoma; Photons; Photosensitizing Agents; Ruthenium; Spheroids, Cellular; Tumor Hypoxia | 2020 |
Brachytherapy of Choroidal Melanomas Less Than 10 mm in Largest Basal Diameter: Comparison of 10-mm and 15-mm Ruthenium Plaques.
Topics: Aged; Brachytherapy; Choroid Neoplasms; Dose-Response Relationship, Radiation; Female; Humans; Male; Melanoma; Middle Aged; Radiotherapy Dosage; Retrospective Studies; Ruthenium; Treatment Outcome; Ultrasonography; Visual Acuity | 2021 |
Topics: Adult; Aged; Aged, 80 and over; Brachytherapy; Female; Humans; Male; Melanoma; Middle Aged; Radiotherapy Dosage; Ruthenium; Uveal Neoplasms; Visual Acuity | 2020 |
Anti-melanoma effect of ruthenium(II)-diphosphine complexes containing naphthoquinone ligand.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Coordination Complexes; Ligands; Male; Melanoma; Mice, Inbred C57BL; Naphthoquinones; Phosphines; Ruthenium | 2021 |
Exploitation of long-lived 3IL excited states for metal-organic photodynamic therapy: verification in a metastatic melanoma model.
Topics: Adult; Cell Line, Tumor; Humans; Lung; Lung Neoplasms; Male; Melanoma; Organometallic Compounds; Photochemotherapy; Photosensitizing Agents; Ruthenium | 2013 |
The synthesis, lipophilicity and cytotoxic effects of new ruthenium(II) arene complexes with chromone derivatives.
Topics: Antineoplastic Agents; Cell Line, Tumor; Chromones; Cytotoxins; Humans; Melanoma; Octanols; Ruthenium | 2016 |
Effects of histidin-2-ylidene vs. imidazol-2-ylidene ligands on the anticancer and antivascular activity of complexes of ruthenium, iridium, platinum, and gold.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Chick Embryo; Gold; Humans; Imidazoles; Iridium; Melanoma; Mice; Neovascularization, Pathologic; Platinum; Ruthenium; Xenograft Model Antitumor Assays | 2016 |
A fluorinated ruthenium porphyrin as a potential photodynamic therapy agent: synthesis, characterization, DNA binding, and melanoma cell studies.
Topics: Absorption; Animals; Apoptosis; Darkness; DNA; DNA, Superhelical; Electrochemistry; Fluorine; Humans; Magnetic Resonance Spectroscopy; Male; Melanoma; Metalloporphyrins; Middle Aged; Photochemotherapy; Photolysis; Ruthenium; Spectrophotometry, Ultraviolet | 2008 |
[Tumor regression in malignant choroidal melanomas after transpupillary thermotherapy (TTT) versus ruthenium brachytherapy and sandwich therapy - a comparative analysis].
Topics: Brachytherapy; Choroid Neoplasms; Female; Humans; Hyperthermia, Induced; Isotopes; Male; Melanoma; Middle Aged; Pupil; Radiopharmaceuticals; Retrospective Studies; Ruthenium; Treatment Outcome | 2010 |
Efficient photodynamic therapy of cancer using chemotherapeutic porphyrin-ruthenium metalla-cubes.
Topics: Antineoplastic Agents; Cations; Cell Line, Tumor; Dose-Response Relationship, Radiation; Female; HeLa Cells; Humans; Inhibitory Concentration 50; Light; Melanoma; Metals; Models, Chemical; Neoplasms; Ovarian Neoplasms; Photochemistry; Photochemotherapy; Photosensitizing Agents; Porphyrins; Ruthenium; Time Factors | 2012 |
Nickel, copper, and zinc centered ruthenium-substituted porphyrins: effect of transition metals on photoinduced DNA cleavage and photoinduced melanoma cell toxicity.
Topics: Animals; Antineoplastic Agents; Cattle; Copper; DNA; DNA Cleavage; DNA, Circular; Humans; Light; Male; Melanoma; Metalloporphyrins; Middle Aged; Nickel; Ruthenium; Structure-Activity Relationship; Transition Elements; Zinc | 2012 |
A simple calibration method for 106Ru-106Rh eye applicators.
Topics: Calibration; Eye Neoplasms; Humans; Melanoma; Radiometry; Radiotherapy; Rhodium; Ruthenium | 2005 |
Light-induced anticancer activity of [RuCl2(DMSO)4] complexes.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Chromatography, High Pressure Liquid; Dimethyl Sulfoxide; DNA; Drug Screening Assays, Antitumor; Heating; Humans; Hydrolysis; Melanoma; Mice; Oligonucleotides; Organometallic Compounds; Photolysis; Prodrugs; Ruthenium; Solutions; Stereoisomerism; Structure-Activity Relationship; Ultraviolet Rays; Water | 2005 |
106Ru/106Rh plaque and proton radiotherapy for ocular melanoma: a comparative dosimetric study.
Topics: Body Burden; Brachytherapy; Computer Simulation; Eye Neoplasms; Humans; Melanoma; Models, Biological; Models, Statistical; Proton Therapy; Radiation Dosage; Radiation Protection; Radioisotopes; Radiometry; Radiotherapy Planning, Computer-Assisted; Relative Biological Effectiveness; Ruthenium; Scattering, Radiation; Treatment Outcome | 2005 |
Visual outcome, local tumour control, and eye preservation after 106Ru/Rh brachytherapy for choroidal melanoma.
Topics: Adult; Aged; Aged, 80 and over; Brachytherapy; Choroid Neoplasms; Eye; Eye Enucleation; Female; Follow-Up Studies; Humans; Male; Melanoma; Middle Aged; Neoplasm Recurrence, Local; Rhodium; Ruthenium; Treatment Outcome; Visual Acuity | 2006 |
An organometallic protein kinase inhibitor pharmacologically activates p53 and induces apoptosis in human melanoma cells.
Topics: Apoptosis; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Melanoma; Mitochondria; Organometallic Compounds; Protein Kinase Inhibitors; Ruthenium; Tumor Suppressor Protein p53; Up-Regulation | 2007 |
Ruthenium porphyrin compounds for photodynamic therapy of cancer.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cytoplasmic Granules; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Lasers; Lysosomes; Melanoma; Models, Molecular; Molecular Structure; Organometallic Compounds; Photochemotherapy; Photosensitizing Agents; Porphyrins; Ruthenium; Tissue Distribution | 2008 |
Electrophysiological findings after radiotherapy of choroidal melanoma.
Topics: Choroid Neoplasms; Cobalt Radioisotopes; Electroretinography; Follow-Up Studies; Humans; Melanoma; Middle Aged; Neoplasm Recurrence, Local; Radiation Injuries; Radioisotopes; Radiotherapy, High-Energy; Retina; Ruthenium | 1984 |
[Treatment of malignant melanomas of the uvea with 106-ruthenium applicators. Report on the first 100 Essen cases].
Topics: Aged; Choroid Neoplasms; Ciliary Body; Dose-Response Relationship, Radiation; Follow-Up Studies; Humans; Melanoma; Middle Aged; Neoplasm Recurrence, Local; Postoperative Complications; Radioisotopes; Ruthenium; Uveal Neoplasms; Visual Acuity | 1984 |
Antineoplastic activity and toxicity of an organometallic complex of ruthenium(II) in comparison with cis-PDD in mice bearing solid malignant neoplasms.
Topics: Animals; Antineoplastic Agents; Blood Cell Count; Cell Survival; Cisplatin; Dose-Response Relationship, Drug; Female; Lung Neoplasms; Mammary Neoplasms, Experimental; Melanoma; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Neoplasms, Experimental; Organometallic Compounds; Ruthenium | 1984 |
The treatment of ciliary body melanoma by beta radiation.
Topics: Adult; Aged; Brachytherapy; Ciliary Body; Electrons; Female; Humans; Male; Melanoma; Middle Aged; Radiation, Ionizing; Radioisotopes; Radiotherapy Dosage; Ruthenium; Uveal Neoplasms | 1983 |
Techniques and results of 106Ru/106Rh radiation of choroidal tumours.
Topics: Adult; Aged; Brachytherapy; Choroid Neoplasms; Female; Humans; Male; Melanoma; Middle Aged; Radioisotopes; Radiotherapy Dosage; Rhodium; Ruthenium; Visual Acuity | 1983 |
[Fluorescence angiography findings following ruthenium treatment of malignant choroid melanomas].
Topics: Choroid Neoplasms; Fluorescein Angiography; Humans; Melanoma; Radioisotopes; Ruthenium | 1983 |
[Radiation retinopathy following treatment of choroid melanomas with 106Ru/106Rh applicators].
Topics: Aged; Choroid Neoplasms; Female; Humans; Male; Melanoma; Radiation Injuries; Radioisotopes; Radiotherapy Dosage; Retina; Rhodium; Ruthenium | 1983 |
[Chorioretinal scarring after radiotherapy of malignant choroidal melanoma with the ruthenium 106 applicator].
Topics: Choroid Neoplasms; Humans; Male; Melanoma; Middle Aged; Radioisotopes; Ruthenium | 1984 |
[Computer tomography studies of patients with choroid melanomas irradiated with 106 ruthenium].
Topics: Aged; Choroid Neoplasms; Female; Humans; Melanoma; Radioisotopes; Radionuclide Imaging; Ruthenium | 1984 |
beta-Irradiation of choroidal melanoma with 106Ru/106Rh applicators. 16 Years' experience.
Topics: Choroid Neoplasms; Evaluation Studies as Topic; Eye Diseases; Follow-Up Studies; Humans; Light Coagulation; Melanoma; Radiation Injuries; Radioisotopes; Rhodium; Ruthenium; Vision, Ocular | 1983 |
[Echographic determination of tumor size and control of the applicator in ruthenium therapy of choroid melanomas].
Topics: Adult; Aged; Brachytherapy; Choroid Neoplasms; Female; Humans; Male; Melanoma; Middle Aged; Patient Care Planning; Ruthenium; Ultrasonography | 1982 |
Intraocular and episcleral melanoma treated with beta radiation (106Ru/106Rh).
Topics: Adult; Choroid Neoplasms; Female; Humans; Melanoma; Neoplasm Recurrence, Local; Radioisotopes; Rhodium; Ruthenium; Sclera | 1980 |
[Results of treatment of malignant melanoma of the choroid using local beta-irradiation (Ru106/Rh106) from 1988 to 1992].
Topics: Beta Particles; Brachytherapy; Choroid Neoplasms; Female; Humans; Isotopes; Male; Melanoma; Middle Aged; Radioisotopes; Rhodium; Ruthenium | 1994 |
The in vivo inhibition of tumor growth by ruthenium red: its relationship with the metabolism of calcium in the tumor.
Topics: Adenocarcinoma; Animals; Biological Transport; Body Weight; Calcium; Intracellular Fluid; Leukemia, Experimental; Leukemia, Lymphoid; Lymphoma, Non-Hodgkin; Magnesium; Melanoma; Mice; Mice, Inbred AKR; Mice, Inbred C3H; Mice, Inbred C57BL; Microsomes; Mitochondria; Neoplasms, Experimental; Phosphorus; Ruthenium; Sarcoma, Experimental | 1975 |
Treatment of choroidal melanomas with 106Ru/106Rh beta-ray applicators.
Topics: Choroid Neoplasms; Humans; Melanoma; Radioisotopes; Rhodium; Ruthenium | 1977 |
[Radiotherapy of intraocular tumours, particularly of melanoma of the choroid (author's transl)].
Topics: Brachytherapy; Choroid Neoplasms; Eye Diseases; Female; Follow-Up Studies; Humans; Male; Melanoma; Middle Aged; Radioisotope Teletherapy; Radioisotopes; Rhodium; Ruthenium | 1979 |
[Complications of the irradiation therapy with beta applicators in malign melanomas (author's transl)].
Topics: Brachytherapy; Choroid Neoplasms; Humans; Macular Degeneration; Melanoma; Radioisotopes; Rhodium; Ruthenium; Uveitis | 1979 |
[Radiotherapy of malignant melanoma of the choroid using the ruthenium-106-applicator].
Topics: Choroid Neoplasms; Humans; Melanoma; Radioisotopes; Radiotherapy; Radiotherapy Dosage; Ruthenium | 1978 |
Hyperthermia inhibition of tumor cells growth in the presence of ruthenium red.
Topics: Animals; Biological Transport; Calcium; Cell Membrane; Hyperthermia, Induced; Melanoma; Rats; Rats, Inbred Strains; Ruthenium; Ruthenium Red; Sarcoma, Experimental | 1986 |
[Report on 50 cases of uveal melanoma treated by conservative beta curietherapy].
Topics: Brachytherapy; Female; Fluorescein Angiography; Humans; Iridium; Male; Melanoma; Radiotherapy Dosage; Ruthenium; Uveal Neoplasms | 1987 |
[10 years' experience with ruthenium 106/rhodium 106 treatment of malignant melanoma of the choroid--report on 264 irradiated tumors].
Topics: Choroid; Choroid Neoplasms; Follow-Up Studies; Humans; Melanoma; Radioisotopes; Radiotherapy Dosage; Rhodium; Ruthenium; Ultrasonography | 1986 |
[Echographic evaluation of malignant melanoma of the uvea following ruthenium therapy].
Topics: Brachytherapy; Humans; Melanoma; Radioisotopes; Ruthenium; Ultrasonography; Uveal Neoplasms | 1986 |
Results after beta-irradiation (106Ru/106Rh) of choroidal melanomas. Twenty years' experience.
Topics: Beta Particles; Choroid Neoplasms; Follow-Up Studies; Humans; Melanoma; Radioisotopes; Radiotherapy Dosage; Rhodium; Ruthenium | 1987 |
[Echocardiography findings before and following beta-irradiation (106Ru/106Rh) of choroid melanoma].
Topics: Choroid; Choroid Neoplasms; Echocardiography; Follow-Up Studies; Humans; Melanoma; Postoperative Complications; Radioisotopes; Rhodium; Ruthenium | 1987 |
[Radiotherapy of malignant melanoma of the choroid with ruthenium-106 applicator gives good results].
Topics: Choroid Neoplasms; Female; Follow-Up Studies; Humans; Male; Melanoma; Middle Aged; Prognosis; Radioisotopes; Ruthenium | 1987 |
Antitumor activity of imidazolium-bisimidazole-tetrachlororuthenate (III). A representative of a new class of inorganic antitumor agents.
Topics: Animals; Antineoplastic Agents; Cisplatin; Cyclophosphamide; Drug Evaluation, Preclinical; Female; Fluorouracil; Imidazoles; Leukemia P388; Melanoma; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Organometallic Compounds; Ruthenium | 1986 |
[Treatment of conjunctival melanoma with ruthenium 106--preliminary report].
Topics: Aged; Conjunctival Neoplasms; Humans; Male; Melanoma; Radioisotopes; Radiotherapy Dosage; Ruthenium | 1986 |
Results of high dose 106-ruthenium irradiation of choroidal melanomas.
Topics: Adult; Aged; Aged, 80 and over; Brachytherapy; Choroid Neoplasms; Female; Humans; Male; Melanoma; Middle Aged; Radioisotopes; Ruthenium | 1986 |
[Optimization of irradiation time in the treatment of malignant melanoma of the choroid with beta applicators (106Ru/106Rh)].
Topics: Animals; Beta Particles; Choroid Neoplasms; Eye; Follow-Up Studies; Humans; Melanoma; Ophthalmoscopy; Rabbits; Radiation Injuries, Experimental; Radioisotopes; Radiotherapy Dosage; Rhodium; Ruthenium; Time Factors | 1986 |
Results after beta-irradiation (106Ru/106Rh) of choroidal melanomas: 20 years' experience.
Topics: Beta Particles; Choroid Neoplasms; Female; Fluorescein Angiography; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Radioisotopes; Rhenium; Ruthenium; Visual Acuity | 1986 |
[Conservative treatment of malignant choroid melanoma by scleral applicators of ruthenium-106. First 25 French cases].
Topics: Adult; Aged; Aged, 80 and over; Brachytherapy; Choroid Neoplasms; Female; France; Humans; Male; Melanoma; Middle Aged; Radioisotopes; Ruthenium | 1986 |
[Treatment of choroid melanoma with contact curietherapy using ruthenium 106].
Topics: Brachytherapy; Choroid Neoplasms; Follow-Up Studies; Humans; Light Coagulation; Melanoma; Radioisotopes; Radiotherapy Dosage; Ruthenium; Time Factors; Visual Acuity | 1985 |
[Treatment of melanomas of the choroid with 106 Ru/106 Rh applicators. Preliminary results].
Topics: Brachytherapy; Choroid Neoplasms; Female; Humans; Male; Melanoma; Radioisotopes; Ruthenium | 1985 |
[Echography findings in choroid melanoblastomas following ruthenium therapy].
Topics: Adult; Aged; Choroid Neoplasms; Female; Humans; Male; Melanoma; Middle Aged; Radioisotopes; Ruthenium; Ultrasonography | 1985 |
[A beta ray applicator (106Ru/106Rh) in the treatment of ciliary body melanomas].
Topics: Brachytherapy; Ciliary Body; Humans; Melanoma; Radioisotopes; Rhodium; Ruthenium; Uveal Neoplasms | 1985 |
[Pretherapeutic computer tomographic studies and follow-up of patients with beta-irradiated choroid melanomas].
Topics: Choroid Neoplasms; Densitometry; Follow-Up Studies; Humans; Melanoma; Radioisotopes; Ruthenium; Tomography, X-Ray Computed | 1985 |
[A procedure for the determination of dose performance of radioactive eye applicators (106-Ru/106-Rh) and their significance for indications and treatment in malignant choroid melanomas].
Topics: Choroid Neoplasms; Humans; Melanoma; Radioisotopes; Radiotherapy Dosage; Rhodium; Ruthenium; Thermoluminescent Dosimetry | 1985 |
Surface properties of human melanoma cells.
Topics: Aged; Cell Transformation, Neoplastic; Choroid; Choroid Neoplasms; Female; Histological Techniques; Humans; Melanoma; Microscopy, Electron; Ruthenium; Staining and Labeling; Surface Properties | 1971 |
Experiences in the treatment of malignant melanoma of the choroid with 106Ru-106Rh beta-ray applicators.
Topics: Adult; Aged; Choroid Neoplasms; Cobalt Radioisotopes; Dose-Response Relationship, Radiation; Female; Humans; Light Coagulation; Macula Lutea; Male; Melanoma; Methods; Middle Aged; Phosphorus Radioisotopes; Radioisotopes; Radiotherapy; Radiotherapy Dosage; Rhodium; Ruthenium; Visual Acuity | 1973 |